• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苏拉明结构类似物对肿瘤坏死因子-α(TNF-α)/TNF-α受体结合的抑制作用

Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin.

作者信息

Mancini F, Toro C M, Mabilia M, Giannangeli M, Pinza M, Milanese C

机构信息

Angelini Ricerche, S. Palomba-Pomezia, Rome.

出版信息

Biochem Pharmacol. 1999 Sep 1;58(5):851-9. doi: 10.1016/s0006-2952(99)00150-1.

DOI:10.1016/s0006-2952(99)00150-1
PMID:10449196
Abstract

Suramin, a symmetrical polysulfonated urea derivative, promotes the dissociation of trimeric human tumor necrosis factor-alpha (TNF-alpha) into biologically inactive subunits and prevents the interaction of TNF-alpha with its cellular receptors. The aim of this work was to identify compounds structurally related to suramin which inhibit the binding of TNF-alpha to its receptor. Molecular modeling studies were performed on suramin and TNF-alpha molecules and likely interaction sites were identified in the docked complex. On this basis, Evans blue, trypan blue, sulfonazo III, beryllon II, and 1,3,6-naphthalenetrisulfonic acid trisodium salt were identified as polysulfonated compounds endowed, to various extents, with the structural characteristics responsible for interaction with TNF-alpha. N,N-bis(3,5-di-tert-butylphenyl)-3,4,9,10-perylenedicarboximide was used as an unrelated structure. The capacity of these molecules to inhibit the binding of TNF-alpha with its receptor p55 was tested in vitro by means of a specific immunoenzymatic assay using suramin as reference compound. Evans blue and trypan blue inhibited TNF-alpha/p55 binding with an IC50 of 0.75 and 1.00 mM, respectively (suramin IC50: 0.65 mM); no effect was observed with the other molecules. Molecular modeling analyses on Evans blue and trypan blue docked into the TNF-alpha molecule support these experimental results by demonstrating that these compounds share with suramin a similar binding mode to TNF-alpha. The results of this work provide a new insight into and useful hints for the design of new chemical entities endowed with a potent and selective activity on TNF-alpha.

摘要

苏拉明是一种对称的多磺酸化尿素衍生物,它能促进三聚体人肿瘤坏死因子-α(TNF-α)解离为无生物活性的亚基,并阻止TNF-α与其细胞受体相互作用。本研究的目的是鉴定与苏拉明结构相关的化合物,这些化合物可抑制TNF-α与其受体的结合。对苏拉明和TNF-α分子进行了分子模拟研究,并在对接复合物中确定了可能的相互作用位点。在此基础上,伊文思蓝、台盼蓝、磺基偶氮III、铍试剂II和1,3,6-萘三磺酸三钠盐被鉴定为多磺酸化化合物,它们在不同程度上具有与TNF-α相互作用的结构特征。N,N-双(3,5-二叔丁基苯基)-3,4,9,10-苝二甲酰亚胺用作无关结构。通过使用苏拉明作为参考化合物的特异性免疫酶测定法,在体外测试了这些分子抑制TNF-α与其受体p55结合的能力。伊文思蓝和台盼蓝抑制TNF-α/p55结合的IC50分别为0.75和1.00 mM(苏拉明的IC50为0.65 mM);其他分子未观察到效果。对对接至TNF-α分子中的伊文思蓝和台盼蓝进行的分子模拟分析表明,这些化合物与苏拉明具有相似的与TNF-α的结合模式,从而支持了这些实验结果。本研究结果为设计对TNF-α具有强效和选择性活性的新化学实体提供了新的见解和有用的提示。

相似文献

1
Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin.苏拉明结构类似物对肿瘤坏死因子-α(TNF-α)/TNF-α受体结合的抑制作用
Biochem Pharmacol. 1999 Sep 1;58(5):851-9. doi: 10.1016/s0006-2952(99)00150-1.
2
Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice.苏拉明在体外可抑制死亡受体诱导的细胞凋亡,并能抑制小鼠暴发性凋亡性肝损伤。
Nat Med. 2004 Jun;10(6):602-9. doi: 10.1038/nm1049. Epub 2004 May 16.
3
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.小分子与肿瘤坏死因子受体-1的光化学增强结合抑制了肿瘤坏死因子-α的结合。
Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):11879-84. doi: 10.1073/pnas.211178398.
4
Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha.苏拉明诱导肿瘤坏死因子α解聚的机制。
Biochemistry. 1995 May 16;34(19):6344-50. doi: 10.1021/bi00019a012.
5
The p55 tumor necrosis factor receptor (CD120a) induces endothelin-1 synthesis in endothelial and epithelial cells.p55肿瘤坏死因子受体(CD120a)可诱导内皮细胞和上皮细胞合成内皮素-1。
Eur J Pharmacol. 2000 Feb 25;390(1-2):89-94. doi: 10.1016/s0014-2999(00)00022-4.
6
HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.1型人类免疫缺陷病毒反式激活因子抑制肿瘤坏死因子α诱导的肿瘤坏死因子受体p55的抑制作用,并增强稳定转染tat的HeLa细胞中肿瘤坏死因子α的活性。
AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1125-32. doi: 10.1089/088922201316912736.
7
The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.锥虫杀药物苏拉明和其他锥虫蓝类似物是丙酮酸激酶的抑制剂,并且与腺苷位点结合。
J Biol Chem. 2011 Sep 9;286(36):31232-40. doi: 10.1074/jbc.M110.212613. Epub 2011 Jul 5.
8
Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I.鉴定Grb2为肿瘤坏死因子(TNF)受体I的新型结合伴侣。
J Exp Med. 1999 Jun 7;189(11):1707-14. doi: 10.1084/jem.189.11.1707.
9
Suramin induces deoligomerization of human tumor necrosis factor alpha.苏拉明可诱导人肿瘤坏死因子α解聚。
J Biol Chem. 1993 Jun 15;268(17):12526-9.
10
Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells.肿瘤坏死因子α-p55受体的激活可诱导心肌细胞增殖,并调节培养的人气管平滑肌细胞中激动剂诱发的钙瞬变。
Am J Respir Cell Mol Biol. 1996 Jul;15(1):55-63. doi: 10.1165/ajrcmb.15.1.8679222.

引用本文的文献

1
Suramin Exerts an Ameliorative Effect on Acetic Acid-Induced Acute Colitis in Rats by Demonstrating Potent Antioxidant and Anti-Inflammatory Properties.苏拉明通过展现强大的抗氧化和抗炎特性,对乙酸诱导的大鼠急性结肠炎发挥改善作用。
Medicina (Kaunas). 2025 Apr 30;61(5):829. doi: 10.3390/medicina61050829.
2
Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis.鉴定可溶性 RANKL 上的结合位点,该位点可作为靶点抑制可溶性 RANK-RANKL 相互作用,从而治疗骨质疏松症。
Nat Commun. 2022 Sep 12;13(1):5338. doi: 10.1038/s41467-022-33006-4.
3
In Silico Identification and Evaluation of Natural Products as Potential Tumor Necrosis Factor Function Inhibitors Using Advanced Enalos Asclepios KNIME Nodes.
基于先进的 Enalos Asclepios KNIME 节点,通过计算机虚拟筛选,鉴定和评估天然产物作为潜在的肿瘤坏死因子功能抑制剂。
Int J Mol Sci. 2021 Sep 23;22(19):10220. doi: 10.3390/ijms221910220.
4
Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future.肿瘤坏死因子α抑制剂在慢性炎症性疾病中的治疗潜力:过去与未来。
Genes Dis. 2020 Mar 3;8(1):38-47. doi: 10.1016/j.gendis.2020.02.004. eCollection 2021 Jan.
5
Diphlorethohydroxycarmalol (DPHC) Isolated from the Brown Alga Acts on Inflammatory Myopathy as an Inhibitory Agent of TNF-α.二苯并呋喃四氢咔啉(DPHC)从褐藻中分离出来,作为 TNF-α 的抑制剂,作用于炎症性肌病。
Mar Drugs. 2020 Oct 26;18(11):529. doi: 10.3390/md18110529.
6
Structure-Based Design, Synthesis and Bioactivity of a New Anti-TNFα Cyclopeptide.基于结构的新型抗 TNFα 环肽的设计、合成与生物活性。
Molecules. 2020 Feb 19;25(4):922. doi: 10.3390/molecules25040922.
7
Using a Consensus Docking Approach to Predict Adverse Drug Reactions in Combination Drug Therapies for Gulf War Illness.采用共识对接方法预测海湾战争疾病联合药物治疗中的药物不良反应。
Int J Mol Sci. 2018 Oct 26;19(11):3355. doi: 10.3390/ijms19113355.
8
Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).植物源肿瘤坏死因子(TNF)和核因子κB受体激活剂配体(RANKL)天然产物抑制剂的发现。
Front Pharmacol. 2018 Jul 25;9:800. doi: 10.3389/fphar.2018.00800. eCollection 2018.
9
Design, Synthesis, and Evaluation of Dihydrobenzo[]indole-6-sulfonamide as TNF-α Inhibitors.二氢苯并[]吲哚-6-磺酰胺作为肿瘤坏死因子-α抑制剂的设计、合成与评价
Front Chem. 2018 Apr 4;6:98. doi: 10.3389/fchem.2018.00098. eCollection 2018.
10
Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.通过联合体内外筛选鉴定一种体内口服活性的双重结合蛋白-蛋白相互作用抑制剂,该抑制剂靶向 TNFα。
Sci Rep. 2017 Jun 13;7(1):3424. doi: 10.1038/s41598-017-03427-z.